¡¥¦ÛµMÂø»x¡¦³Ì·s¤@´Á¬ã¨s³ø§i«ü¥X¤@¨Ç¯S©w³½Ãþ,°íªGÃþ,´Óª«ªoµ¥¹ª«¤¤´I§tªºomega-3¦h¤¸¥¼¹¡©M¯×ªÕ»Ä(PUFA)¯à°÷ªý¤î²´¯e¶i¤@¨B´c¤Æ. omega-3¯×ªÕ»Ä¤¤ªº¥Dn¦¨¥÷ -
¤G¤Q¤GºÒ¤»²m»Ä(DHA)¤Î¤G¤QºÒ¤²m»Ä(EPA)°£¤F¥i¥HÀ°§U¹w¨¾µøºô½¤¯fÅÜ¥~,ÁÙ¥i¥H±j¤Æ¤ßŦ. ¨Ó¦Û«¢¦òÂå¾Ç°|ªº°Æ±Ð±ÂDr. Lois E. H. Smith´Nªí¥Ü:¡¨¹ï©óÂå¥Í¶}¥ß³oºØ§C¦¨¥»ªº«D³B¤èÀç¾i¸É«~µ¹¯f¤H¦Ó¨¥,µ´¹ï¬OÂùĹ.¡¨
¤£·í²£¥Íªºµøºô½¤¦åºÞ¼W¥Í³Ì«á·|¾ÉP¯f±w¥¢©ú,¬ã¨s¤Hû«K°w¹ï¨ã¦³¤£¥¿±`µøºô½¤¦åºÞ¼W¥Íªº¦Ñ¹«¶i¦æ¤@¨t¦Cªº¹êÅç;ÂÇ¥Hµû¦ôomega-3-PUFA»Pomega-6-PUFA(§@¥Î»Pomega-3-PUFA«ê¦n¬Û¤Ï;omega-6-PUFA§t¶q¹L¦h·|³y¦¨¦åºÞ¼W¥Í)¹ï©ó¦Ñ¹«ªº¼vÅT. µ²ªG¬ã¨s¤Hûµo²{¦b¦Ñ¹«¨¤W¼W¥[Àç¾i¸É¥R¾¯omega-3-PUFAªº§t¶q·|¾ÉP¦Ñ¹«Å餺omega-6-PUFA¬Û¹ï©óomega-3-PUFAªº¤ñ¨Ò´î¤Ö¶W¹L50%,¦Ó³oÓ§@¥Î»P«OÅ@²´·ú¤Î¨¾¤î¨ä¯f²z¹Lµ{¦³µÛ¬Û·í¤jªºÃö³s.
¼W¥[Å餺omega-3-PUFAªº§t¶q·|´î¤Öµøºô½¤©PÃä¦åºÞªº¥Íªø,Äá¨úl¥Í¦ÛDHA»PEPAªº¬¡¤Æ¥Íª«²£«~¹ï©ó²´·ú©PÃä¦åºÞ¦³«Ü¤jªº«OÅ@§@¥Î;´«¨¥¤§, omega-3-PUFA¯à°÷¨ó§U¹ï§Üµøºô½¤¯fÅܨä¹ê³¡¥÷¬O³z¹L¥¦¨ä¤¤©Ò§tDHA»PEPA¨Ó¶Ç»¼°T®§»P¹B§@ªº. ¨ä¥¦ªº¹êÅç¤]Åã¥Ü¼W¥[omega-3-PUFAªº§t¶q¦³¹w¨¾µøºô½¤¯fÅܪº§@¥Î´N¹³¬O¦b¹ï§Üµøºô½¤¯fÅܪº¹Lµ{¤¤¦³²Õ¥Õ¦å²y³]©w¤@³s¦êªº¬¡°Ê¨Ó©è§Ü¥~ª««I¤J¤@¯ë.
Dr. Smith»{¬°¥¼¨Óªº¬ã¨s«ÂI±NµÛ«©óomega-3Àç¾i¸É¥R«~¹ï©ó¡¦¦Ñ¦~©Ê¶À´³¯fÅÜ¡¦(age-related macular degeneration)¤Î¹ï©ó¡¦¿}§¿¯fµøºô½¤¯fÅÜ¡¦(diabetic
retinopathy)ªº¼vÅT.
°Ñ¦Ò¸ê®Æ: (1) ¡¨Omega-3 fatty acids slow eye disease progression¡¨ (
http://www.reutershealth.com/en/index.html
http://www.eurekalert.org/pub_releases/2007-06/nei-ofa061907.php
http://in.news.yahoo.com/070625/139/6hcv8.html